SEC22B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.173000E-01
Normal-vs-Stage2
8.820200E-01
Normal-vs-Stage3
1.781590E-01
Normal-vs-Stage4
2.253000E-01
Stage1-vs-Stage2
9.947600E-01
Stage1-vs-Stage3
3.461400E-01
Stage1-vs-Stage4
3.045000E-01
Stage2-vs-Stage3
1.873050E-01
Stage2-vs-Stage4
1.048560E-01
Stage3-vs-Stage4
3.677700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.214800E-01
Normal-vs-AfricanAmerican
2.230600E-01
Normal-vs-Asian
8.606800E-01
Caucasian-vs-AfricanAmerican
2.474400E-01
Caucasian-vs-Asian
8.312800E-01
AfricanAmerican-vs-Asian
4.286400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.760600E-01
Normal-vs-Female
7.530200E-01
Male-vs-Female
2.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.595600E-01
Normal-vs-Age(41-60Yrs)
6.334400E-01
Normal-vs-Age(61-80Yrs)
9.744600E-01
Normal-vs-Age(81-100Yrs)
9.120800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.656800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.464600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.651000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.505830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.929600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.516800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.940000E-01
Normal-vs-Daily Drinker
3.199200E-01
Normal-vs-Weekly Drinker
7.391600E-01
Normal-vs-Occasional Drinker
8.711400E-01
Normal-vs-Social Drinker
6.125800E-01
Non Drinker-vs-Daily Drinker
3.616800E-01
Non Drinker-vs-Weekly Drinker
2.062200E-01
Non Drinker-vs-Occasional Drinker
1.723420E-01
Non Drinker-vs-Social Drinker
9.727800E-02
Daily Drinker-vs-Weekly Drinker
9.312000E-02
Daily Drinker-vs-Occasional Drinker
3.832300E-02
Daily Drinker-vs-Social Drinker
3.804300E-02
Weekly Drinker-vs-Occasional Drinker
6.320600E-01
Weekly Drinker-vs-Social Drinker
7.912000E-01
Occasional Drinker-vs-Social Drinker
4.033800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.698800E-01
Normal-vs-Grade 2
8.103000E-01
Normal-vs-Grade 3
8.401000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.187600E-01
Grade 1-vs-Grade 3
8.938200E-01
Grade 1-vs-Grade 4
6.698800E-01
Grade 2-vs-Grade 3
5.955600E-01
Grade 2-vs-Grade 4
8.103000E-01
Grade 3-vs-Grade 4
8.401000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.980800E-01
Normal-vs-NonDiabetic
9.750400E-01
Diabetic-vs-NonDiabetic
9.308600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.323800E-01
Normal-vs-NoPancreatitis
9.849000E-01
Pancreatitis-vs-NoPancreatitis
4.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.651000E-01
Normal-vs-N1
8.697000E-01
N0-vs-N1
8.179000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.192000E-01
Normal-vs-TP53-NonMutant
7.524200E-01
TP53-Mutant-vs-TP53-NonMutant
8.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
